| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.25 | 5e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |